Express News | Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
50 Stocks That May See Selling Pressure as Investors Begin Looking to Book Tax Losses
Enovis Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
Investors in Enovis (NYSE:ENOV) From Three Years Ago Are Still Down 47%, Even After 3.2% Gain This Past Week
Enovis Continues to Redefine Revision Knee Surgery With the Addition of EMPOWR Cones to EMPOWR Revision Knee, Creating a Comprehensive Portfolio for Efficient Revision Procedures
Enovis Introduces STAR Ankle, Now With E+ Polyethylene for Unmatched Durability